ArticleMolecular biology reports2025
Co-occurrence of homozygous ALMS1 variant, 17q11.2 mosaic and germline deletions, and VSX2 nonsense variant in a single family.
Article in Molecular biology reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introduction: Alström syndrome (AS) is a rare, progressive disorder inherited in an autosomal recessive manner. It is characterized by multisystem involvement, including retinal dystrophy, hearing loss, obesity, insulin resistance, and cardiomyopathy. AS is typically associated with biallelic pathogenic variants in the ALMS1 gene. In this study, three distinct inherited disorders caused by different genetic mechanisms observed within the same family were evaluated together.
objectiveThree sisters were diagnosed with ALMS1-related Alström syndrome; in one proband, mosaic and germline deletions at the 17q11.2 region were identified, and a novel homozygous nonsense variant in the VSX2 gene was detected in family members with vision loss. This study aims to present the clinical and molecular characteristics of these three rare genetic events occurring within the same family.
methodsPhysical examination, imaging, developmental assessment, and biochemical tests were performed on the probands and family members. Genetic analyses included conventional karyotyping, SNP array, and whole exome sequencing (WES).
resultsA novel homozygous nonsense variant (c.6288T > A, p.Tyr2096Ter) in the ALMS1 gene, not previously reported, was identified in the three sisters. In proband 1, a 998 kb mosaic deletion encompassing the gene (~ 80–85% mosaicism) and an additional 310 kb germline deletion not including NF1 were detected at the 17q11.2 locus. A novel homozygous nonsense variant (c.753G > A, p.Trp251Ter) in the VSX2 gene was found in the vision-impaired maternal uncle and aunt.
conclusionThis study is the first to report the coexistence of a novel ALMS1 variant causing Alström syndrome, mosaic and germline deletions at the 17q11.2 region, and a novel pathogenic variant in the VSX2 gene within the same family. These findings highlight the importance of expanded genetic analyses and comprehensive evaluation of family members in diagnosing rare diseases.
Indexed as
Identifiers
40982094What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.